ArticleArchives of gynecology and obstetrics2025
Functional hypothalamic amenorrhea (FHA) in women with normal body mass index (BMI): metabolic and hormonal profiles.
Article in Archives of gynecology and obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo determine metabolic and hormonal profiles in women with functional hypothalamic amenorrhea (FHA) with normal body mass index (BMI).
methodsIn FHA (n = 69) and controls (n = 69), matched for age and BMI lipid, fasting plasma glucose (FPG) and insulin (Ins) levels along with hormonal profile were determined.
resultsFHA showed slightly lower FPG (- 8.2%, p = 0.001) contrary to the controls with no differences in lipid profile. In the FHA group, BMI was positively correlated with Ins (r = 0.57, p < 0.001) and negatively with high-density lipoprotein cholesterol (HDL-C; r = - 0.58, p < 0.001). Regarding hormonal profile, FHA showed higher prolactin (PRL; + 61.6%) and thyroid-stimulating hormone (TSH; + 4.0%) levels compared to the controls (all p < 0.05). FHA had higher androgen levels reflected by higher total testosterone (TT; + 22.2%) and 17-hydroxyprogesterone (17-OHP; + 88.9%) levels (all p < 0.05) in contrary to the remainder.
conclusionFHA women with normal BMI present unfavorably altered hormonal profile reflected by hyperandrogenemia and slightly lower, but significant, FPG level. The findings confirm the importance of assessing both metabolic and hormonal panels in FHA women despite normal BMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.